Board of Directors

Fate’s Board of Directors has founded and led the evolution of several of the most successful companies in the biotechnology space. The group has deep expertise in science, technology, drug development, finance, and strategy – all the tools necessary to help Fate emerge as an industry leader in the development and commercialization of programmed cellular immunotherapies.

William Rastetter, Ph.D.
John Mendlein, Ph.D.
Vice Chairman
Timothy P. Coughlin
Board Member
Robert S. Epstein, M.D.
Board Member
4bio goes here
Karin Jooss, Ph.D.
Board Member
Michael Lee
Board Member
Amir Nashat, Ph.D.
Board Member
Scott Wolchko
President & CEO
8bio goes here
Dr. Shefali Agarwal
Board Member
10bio goes here